Bayesian analysis and classification of two enzyme-linked immunosorbent assay tests without a gold standard

被引:0
|
作者
Zhang, Jingyang [1 ,2 ]
Chaloner, Kathryn [2 ,3 ]
McLinden, James H. [4 ]
Stapleton, Jack T. [4 ]
机构
[1] Fred Hutchinson Canc Res Ctr, Vaccine & Infect Dis Div, Seattle, WA 98109 USA
[2] Univ Iowa, Dept Biostat, Iowa City, IA USA
[3] Univ Iowa, Dept Stat & Actuarial Sci, Iowa City, IA 52242 USA
[4] Univ Iowa, Dept Internal Med, Iowa City, IA 52242 USA
基金
美国国家卫生研究院;
关键词
Bayesian analysis; Bayesian decision theory; diagnostic testing; mixture model; GB-VIRUS-C; TRUE DISEASE STATE; DIAGNOSTIC-TESTS; NONPARAMETRIC-ESTIMATION; CONDITIONAL DEPENDENCE; ENVELOPE PROTEIN; ERROR RATES; ROC CURVES; PREVALENCE; ABSENCE;
D O I
10.1002/sim.5816
中图分类号
Q [生物科学];
学科分类号
07 ; 0710 ; 09 ;
摘要
Reconciling two quantitative enzyme-linked immunosorbent assay tests for an antibody to an RNA virus, in a situation without a gold standard and where false negatives may occur, is the motivation for this work. False negatives occur when access of the antibody to the binding site is blocked. On the basis of the mechanism of the assay, a mixture of four bivariate normal distributions is proposed with the mixture probabilities depending on a two-stage latent variable model including the prevalence of the antibody in the population and the probabilities of blocking on each test. There is prior information on the prevalence of the antibody, and also on the probability of false negatives, and so a Bayesian analysis is used. The dependence between the two tests is modeled to be consistent with the biological mechanism. Bayesian decision theory is utilized for classification.The proposed method is applied to the motivating data set to classify the data into two groups: those with and those without the antibody. Simulation studies describe the properties of the estimation and the classification. Sensitivity to the choice of the prior distribution is also addressed by simulation. The same model with two levels of latent variables is applicable in other testing procedures such as quantitative polymerase chain reaction tests, where false negatives occur when there is a mutation in the primer sequence. Copyright (c) 2013 John Wiley & Sons, Ltd.
引用
收藏
页码:4102 / 4117
页数:16
相关论文
共 50 条
  • [2] Enzyme Immunoassay and Enzyme-Linked Immunosorbent Assay
    Gan, Stephanie D.
    Patel, Kruti R.
    JOURNAL OF INVESTIGATIVE DERMATOLOGY, 2013, 133 (09) : E10 - E12
  • [3] Analysis of hexazinone in soil by enzyme-linked immunosorbent assay
    Bushway, RJ
    Katz, LE
    Perkins, LB
    Reed, AW
    Fan, TS
    Young, BS
    IMMUNOCHEMICAL TECHNOLOGY FOR ENVIRONMENTAL APPLICATIONS, 1997, 657 : 303 - 311
  • [4] ENZYME-LINKED IMMUNOSORBENT CHORIOMAMMOTROPIN ASSAY
    DITTMAR, D
    MONJI, M
    CID, A
    MALKUS, H
    CASTRO, A
    CLINICAL CHEMISTRY, 1978, 24 (06) : 1032 - 1032
  • [5] ENZYME-LINKED IMMUNOSORBENT-ASSAY
    STANDEFER, JE
    CLINICAL CHEMISTRY, 1981, 27 (06) : 970 - 971
  • [6] Clickable Enzyme-Linked Immunosorbent Assay
    Canalle, Luiz A.
    Vong, TuHa
    Adams, P. Hans H. M.
    van Delft, Floris L.
    Raats, Jos M. H.
    Chirivi, Renato G. S.
    van Hest, Jan C. M.
    BIOMACROMOLECULES, 2011, 12 (10) : 3692 - 3697
  • [7] Enzyme-linked immunosorbent assay (ELISA)
    Kendall, LV
    Riley, LK
    CONTEMPORARY TOPICS IN LABORATORY ANIMAL SCIENCE, 1999, 38 (02): : 46 - 47
  • [8] ENZYME-LINKED IMMUNOSORBENT ASSAY (ELISA)
    DUVIVIER, J
    ANNALES DE BIOLOGIE CLINIQUE, 1978, 36 (04) : 389 - 391
  • [9] ENZYME-LINKED IMMUNOSORBENT CHORIOMAMMOTROPIN ASSAY
    DITTMAR, D
    MONJI, N
    CID, A
    MALKUS, H
    CASTRO, A
    CLINICAL CHEMISTRY, 1979, 25 (02) : 227 - 229
  • [10] ELISA - ENZYME-LINKED IMMUNOSORBENT ASSAY
    YOLKEN, RH
    HOSPITAL PRACTICE, 1978, 13 (12): : 121 - 127